Evidence builds for aspirin’s benefit in GI cancers

VIENNA – Postdiagnosis aspirin use nearly doubled survival in patients with gastrointestinal cancers in a large study from the Netherlands.

After 5 years, 75% of daily low-dose–aspirin users were...